Search all trials

Find therapies in clinical trials near you – page 61

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Thrombotic thrombocytopenic purpura

Not recruiting

Registered drugNo placebo

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Caplacizumab

Contact Research Centre

Adrenogenital syndrome

Not recruiting

Investigational

Study on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Crinecerfont

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

Registered drugNo placebo

Austria

Participants:65+ years
Substances:Ranibizumab

Contact Research Centre

Hereditary angioedema with C1 esterase inhibitor deficiency

Not recruiting

Registered drug

Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

Registered drug

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deucrictibant

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Registered drugNo placebo

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Migraine+3

Not recruiting

Registered drug

Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Atogepant

Contact Research Centre

Find therapies in clinical trials near you – page 61

838 trials match your criteria

Thrombotic thrombocytopenic purpura

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Adrenogenital syndrome

Study on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia

Bladder cancer

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Breast cancer+1

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Age-related macular degeneration

Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

Hereditary angioedema with C1 esterase inhibitor deficiency

Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

Plasma cell myeloma

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Gastrooesophageal cancer

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Chronic lymphocytic leukaemia

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Migraine+3

Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.